Coval Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Ujjain, Madhya Pradesh, India, established in 2021.
2021 Ujjain, Madhya Pradesh, India Active
Last Updated:
Access Report
About Coval Pharmaceuticals Private Limited

Coval Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2021 in Ujjain, Madhya Pradesh, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299MP2021PTC057395. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Prashant Ankushe (Director), Sakharam Ankushe (Director). It is based at 10 Ka Bhag Kalptaru Extension, Lalpur,, Ujjain, Madhya Pradesh, 456010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299MP2021PTC057395

  • Registration Number

    057395

  • Incorporation Date

    08 September 2021

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 5 Months
Company report

Coval Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Coval Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Coval Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Prashant Ankushe Director 08 Sep 2021 Current
Sakharam Ankushe Director 08 Sep 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Coval Pharmaceuticals.

Enhance accessibility to Coval Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Coval Pharmaceuticals revenue growth over time
Coval Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Coval Pharmaceuticals?

Unlock access to Coval Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Coval Pharmaceuticals?

Coval Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Coval Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coval Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Coval Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Prashant Ankushe was appointed as a Director was appointed as a Director on 08 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sakharam Ankushe was appointed as a Director was appointed as a Director on 08 Sep 2021 & has been associated with this company since 4 years 5 months . was documented.

  • Company Incorporation

    The activity Coval Pharmaceuticals Private Limited was registered on 08 Sep 2021 with Roc Gwalior & aged 4 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Coval Pharmaceuticals Private Limited?

The CIN of Coval Pharmaceuticals Private Limited is U24299MP2021PTC057395.

Where is Coval Pharmaceuticals Private Limited headquartered?

Coval Pharmaceuticals Private Limited is headquartered at 10 Ka Bhag Kalptaru Extension, Lalpur,, Ujjain, Madhya Pradesh, 456010.

When was Coval Pharmaceuticals Private Limited incorporated?

Coval Pharmaceuticals Private Limited was incorporated on 08 September 2021.

Who are the current directors of Coval Pharmaceuticals Private Limited?

The current directors of Coval Pharmaceuticals Private Limited are

What is the primary industry of Coval Pharmaceuticals Private Limited?

The primary industry of Coval Pharmaceuticals Private Limited is Chemicals.

Is Coval Pharmaceuticals Private Limited a listed company?

Coval Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Coval Pharmaceuticals Private Limited?

The authorized capital of Coval Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available